Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
Deal marks the second bolt-on for the business, following the acquisition of Swiss diagnostic imaging provider IRD
Deal marks the second investment made from the GP's 2016-vintage sixth vehicle, which closed on £660m
Acquisition is the company's first out of two planned for this year with ActoMezz's backing
Total commitments for the fund fell some way short of the vehicle's €350m target and €400m hard-cap